PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,790 | +17.1% | 25,000 | 0.0% | 0.00% | – |
| Q2 2023 | $1,528 | +52.3% | 25,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,003 | -7.0% | 25,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,078 | -46.1% | 25,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 25,000 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 25,000 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -54.5% | 25,000 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 163,538 | $1,782,564 | 0.12% |
| MMCAP International Inc. SPC | 375,000 | $22,913 | 0.01% |
| Atalaya Capital Management LP | 225,000 | $13,500 | 0.01% |
| Q Global Advisors, LLC | 170,785 | $10 | 0.01% |
| PERISCOPE CAPITAL INC. | 957,098 | $61,858 | 0.01% |
| CVI Holdings, LLC | 47,306 | $2,890 | 0.00% |
| Segantii Capital Management Ltd | 5,000 | $54,500 | 0.00% |
| Silver Rock Financial LP | 23,120 | $1,410 | 0.00% |
| Castle Creek Arbitrage, LLC | 200,000 | $12,220 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 714,827 | $43,604 | 0.00% |